Ativan shortage exposes fragile economics of essential drugs in Korea

“South Korea is facing a looming shortage of injectable lorazepam, an emergency drug used to treat acute seizures and severe agitation, after the country’s sole domestic producer halted production amid tighter manufacturing rules and low government-set prices. Doctors warn that supplies of the medication, sold under the brand name Ativan, could run out within months, forcing hospitals to rely on substitute drugs that may carry greater risks or require more intensive monitoring. The case has renew

Summary generated from the RSS feed of Korea Herald National. All article rights belong to the original publisher. Click through to read the full piece on www.koreaherald.com.